Screen-Printed Sensor for Low-Cost Chloride Analysis in Sweat for Rapid Diagnosis and Monitoring of Cystic Fibrosis

• Published in: Biosensors (Basel) Vol. 10; no. 9; p. 123
• Main Authors: Hauke, Alicia, Oertel, Susanne, Knoke, Leona, Fein, Vanessa, Maier, Christoph, Brinkmann, Folke, Jank, Michael P M
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 11-09-2020; MDPI
• Subjects: Biosensing Techniques; Biosensors; Calibration; Chemical properties; Chloride; Chlorides; Chlorides - analysis; Complications; Conductance; Cost analysis; COVID-19; Cystic fibrosis; Cystic Fibrosis - diagnosis; Cystic Fibrosis Transmembrane Conductance Regulator; Diagnosis; Electrodes; Health aspects; Humans; Hygiene; ion-selective electrode; Iontophoresis; Low cost; Measurement; Modulators; Pandemics; Patients; Perspiration; Physiological aspects; Portable equipment; Remote monitoring; Remote sensors; Response time; screen-printed sensor; Sensors; Sweat; Sweat - chemistry; sweat analysis; Germany; ion-selective electrode; chloride; screen-printed sensor; sweat analysis; cystic fibrosis
• ISSN: 2079-6374; 2079-6374
• DOI: 10.3390/bios10090123

Analysis of sweat chloride levels in cystic fibrosis (CF) patients is essential not only for diagnosis but also for the monitoring of therapeutic responses to new drugs, such as cystic fibrosis transmembrane conductance regulator (CFTR) modulators and potentiators. Using iontophoresis as the gold standard can cause complications like burns, is uncomfortable, and requires repetitive hospital visits, which can be particularly problematic during a pandemic, where distancing and hygiene requirements are increased; therefore, it is necessary to develop fast and simple measures for the diagnosis and monitoring of CF. A screen-printed, low-cost chloride sensor was developed to remotely monitor CF patients. Using potentiometric measurements, the performance of the sensor was tested. It showed good sensitivity and a detection limit of 2.7 × 10
mol/L, which covered more than the complete concentration range of interest for CF diagnosis. Due to its fast response of 30 s, it competes well with standard sensor systems. It also offers significantly reduced costs and can be used as a portable device. The analysis of real sweat samples from healthy subjects, as well as CF patients, demonstrates a proper distinction using the screen-printed sensor. This approach presents an attractive remote measurement alternative for fast, simple, and low-cost CF diagnosis and monitoring.